secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001213900-26-031587
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BiomX amends warrants to 1-year term at $1 exercise; outlines strategic reset
-----------------------------------------------------------------------------

- Warrant term shortened to expire Dec 31, 2026; exercise price reduced from $2.00 to $1.00 per share.
- CEO letter cites warrant overhang reduction and plans to reposition toward defense-related technologies.
- Company finalizing closure of Maryland facility to cut overhead and strengthen financial foundation.
- Active engagement with investment banks and institutional investors for future capital access.
- No change in number of shares issuable upon exercise; cashless exercise VWAP formula revised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026031587/0001213900-26-031587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026031587/ea0282582-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-031587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer